Bring 24-hour relief into their routine
GRALISE is the only true once‑a‑day gabapentinoid that offers Night to Day control of PHN pain1
INDICATIONS AND USAGE
GRALISE is indicated for the management of postherpetic neuralgia (PHN). GRALISE is not interchangeable with other gabapentin products because of differing pharmacokinetic profiles that affect the frequency of administration.
IMPORTANT SAFETY INFORMATION
GRALISE is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients.
WARNINGS AND PRECAUTIONS
The safety and efficacy of GRALISE in patients with epilepsy has not been studied.
The most common side effects were dizziness (10.9%) and somnolence (4.5%).
USE IN SPECIFIC POPULATIONS
Reductions in GRALISE dose should be made in patients with age-related compromised renal function.
Reference: 1. GRALISE [prescribing information]. Newark, CA: Depomed Inc.; December 2012.